FIELD: chemistry; medicine.
SUBSTANCE: in novel triazole derivatives of general formula I or their pharmaceutically acceptable salts R4 is hydrogen; X is selected from group, consisting of single bond, NH- and groups: , values of R1-R3 radicals are given in description, pharmaceutical composition containing them, and application of novel compounds for obtaining medication for treating hyperglycemia, insulin-resistance, type 2 diabetes, fat exchange derangements, obesity, atheroslerosis and metabolic syndrome.
EFFECT: medications possess higher efficiency.
26 cl, 8 ex, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF ENDOSOMAL TOLL-LIKE RECEPTORS | 2017 |
|
RU2759678C2 |
TRICYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITION CONTAINING THEM AND USING THEM FOR TREATING IMMUNOLOGICAL AND ONCOLOGICAL COMPOUNDS | 2009 |
|
RU2545023C9 |
COMPOUND WITH A CYCLIC STRUCTURE | 2018 |
|
RU2795119C2 |
MODULATORS OF INTEGRATED STRESS SIGNALING PATH | 2017 |
|
RU2769327C2 |
CYCLIC INHIBITORS OF 11BETA-HYDROXYSTEROID-DEHYDROGENASE 1 | 2009 |
|
RU2539979C2 |
METHOD OF PRODUCING SOME 2-(PYRIDIN-3-YL)THIAZOLES | 2013 |
|
RU2649000C2 |
ALKALOID ESTER AND CARBAMATE DERIVATIVES AND MEDICINAL COMPOSITIONS THEREOF | 2012 |
|
RU2611627C2 |
METHOD FOR PREPARING CYCLIC DIKETONES | 2003 |
|
RU2316544C2 |
METHODS OF PRODUCING SOME 2-(PYRIDIN-3-YL)THIAZOLES | 2013 |
|
RU2647851C2 |
TYPE 1 DIACYLGLYCEROL O-ACYLTRANSFERASE ENZYME INHIBITORS | 2008 |
|
RU2497816C2 |
Authors
Dates
2009-07-10—Published
2003-12-16—Filed